The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian Carcinoma

Author： Chi D.S. Venkatraman E.S. Masson V. Hoskins W.J.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.77, Iss.2, 2000-05, pp. : 227-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?

By Saygili U. Guclu S. Uslu T. Erten O. Demir N. Onvural A.

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 57-61

Academic Press

Access to resources Recommend Favorite

Preoperative Value of CA 125 as a Reflection of Tumor Grade in Epithelial Ovarian Cancer

By But I. Gorisek B.

Gynecologic Oncology, Vol. 63, Iss. 2, 1996-11 ,pp. : 166-172

Academic Press

Access to resources Recommend Favorite

Preoperative CA-125 Levels in Patients with Hereditary Compared to Sporadic Epithelial Ovarian Carcinoma

By Leitao M. Boyd J.

Gynecologic Oncology, Vol. 84, Iss. 3, 2002-03 ,pp. : 413-415

Elsevier

Access to resources Recommend Favorite

Preoperative Prediction of Optimal Resectability in Advanced Ovarian Cancer Using CA-125

By Berek J.S.

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 225-226

Elsevier

Access to resources Recommend Favorite

Effect of Topotecan on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By Nielsen H.A. Nielsen D. Engelholm S.A.

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite